Bexion Pharmaceuticals, Inc. to Present at the 2023 American Association for Cancer Research (AACR) Annual Meeting and the International Ceramide Conference (ICC)

/PRNewswire/ -- Bexion Pharmaceuticals, Inc., a mid-stage clinical biopharmaceutical company developing a new generation of biologic immunotherapy to treat...

Related Keywords

United States ,Charleston ,South Carolina ,Orlando ,Florida ,American ,Gilles Tapolsky ,American Association For Cancer Research ,American Association For Cancer Research Annual Meeting ,Bexion Pharmaceuticals ,International Ceramide Conference ,Viral Properties ,Bexion Pharmaceuticals Inc ,Cancer Research Annual Meeting ,Direct Toxicity ,Novel Biologic ,Innovative Mechanism ,Action Targeting Sphingolipid Metabolism ,Induces Cancer Cell Death ,Targeting Sphingolipids ,Anticancer Activity ,Modulating Ceramide ,Anti Tumor Activity ,Cancer Patients ,Modulates Sphingolipid Metabolism ,Demonstrates Anti Cancer ,Glioblastoma Multiforme ,American Association ,Cancer Research ,Nc ,